Antimicrobial

Vivid Dx Raises $15M to Help Hospitals Confront One of Modern Medicine’s Most Urgent Threats: Drug-Resistant Infections

As antimicrobial resistance accelerates, when every hour can matter, faster diagnostics can help clinicians get patients on the right antibiotics...

Vivid Dx Raises $15M to Help Hospitals Confront One of Modern Medicine’s Most Urgent Threats: Drug-Resistant Infections

As antimicrobial resistance accelerates, when every hour can matter, faster diagnostics can help clinicians get patients on the right antibiotics...

Lakewood-Amedex Biotherapeutics Announces World-Renowned Expert David G. Armstrong, M.D., Ph.D., as Study Chair for Phase 2a Trial of Nu-3 in Infected Diabetic Foot Ulcers

Leading clinician and surgeon to also serve as Scientific Advisor for Lakewood-Amedex Biotherapeutics' iDFU programSARASOTA, Fla., June 25, 2026 /PRNewswire/...

In HelloNation, Dental Expert Dr. Amy E. Schmitt-Kingston Reviews Dental Cleaning, Professional Cleaning, Oral Health, Gum Disease, Cavities, Routine Dental Exam, and Teeth Maintenance

The article explains how often adults should schedule cleanings and why consistent visits protect long-term oral health.SPRINGVILLE, N.Y., June 18,...

In HelloNation, Dental Expert Dr. Amy E. Schmitt-Kingston Reviews Dental Cleaning, Professional Cleaning, Oral Health, Gum Disease, Cavities, Routine Dental Exam, and Teeth Maintenance

The article explains how often adults should schedule cleanings and why consistent visits protect long-term oral health.SPRINGVILLE, N.Y., June 18,...

Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots — the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product

SINGAPORE, June 15, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“CUPR” or “the Company”), a biomedical company...

Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway

Key Highlights Record revenue, continued momentum: all-time high $65.3M in FY2025; strongest-ever Q1 2026, carrying into Q2.Record operational momentum: CosmoFarm...

error: Content is protected !!